Welcome to our dedicated page for Sherwin-Williams SEC filings (Ticker: SHW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sherwin-Williams Company filings document operating results, governance actions, and capital-structure matters for an Ohio paint and coatings issuer with common stock listed on the New York Stock Exchange under SHW. Recent Form 8-K reports furnish quarterly and annual financial results, including net sales, earnings measures, segment performance, guidance, and Valspar acquisition-related amortization.
Proxy and annual-meeting filings cover director elections, advisory executive-compensation votes, auditor ratification, shareholder voting results, and pay-versus-performance disclosures. Other 8-K filings record material definitive agreements, amendments to credit facilities, borrowing and letter-of-credit commitments, covenants, events of default, and related direct financial obligations.
The Vanguard Group filed an amended ownership report showing a significant stake in The Sherwin-Williams Company. Vanguard reports beneficial ownership of 23,237,722 shares of Sherwin-Williams common stock, representing 9.37% of the outstanding class.
Vanguard reports shared voting power over 2,278,267 shares and shared dispositive power over 23,237,722 shares, with no sole voting or dispositive power. The filing notes that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries or business divisions are expected to report beneficial ownership separately while pursuing the same investment strategies as before.
The Sherwin-Williams Company filed a current report to furnish its latest financial update. On January 29, 2026, the company issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025, along with certain additional information. The press release is included as Exhibit 99.1 and is incorporated by reference, but is treated as “furnished” rather than “filed,” which limits potential liability and controls how the information may be used in other securities filings.
The Sherwin-Williams Company director Thomas Williams reported an automatic equity award under a director fee plan. On 01/09/2026 he acquired 97.66 deferred stock units tied to Sherwin-Williams common stock through the 2005 Director Deferred Fee Plan, using a weighted average share price of $345.60 to calculate the units. Each deferred stock unit is economically equal to one share of common stock and will be paid in stock, generally after he leaves the board. After this transaction, he held a total of 1,053.14 deferred stock units indirectly under the Deferred Fee Plan, and 1,813 directly held equity interests made up of 1,147 restricted stock units and 666 shares of common stock.
Sherwin-Williams director Michael H. Thaman reported an automatic grant of deferred stock units under the company’s 2005 Director Deferred Fee Plan. On January 9, 2026, he acquired 97.66 deferred stock units linked to Sherwin-Williams common stock at a weighted average share price of $345.6, in an exempt transaction under this plan. After this credit, he held 5,480.97 deferred stock units indirectly in the Deferred Fee Plan, which will generally be paid out in stock after he leaves the board. He also reported 7,553 securities held directly, consisting of 1,150 restricted stock units and 6,403 shares of common stock, where each RSU represents the right to receive one share.
The Sherwin-Williams Company director Robert James Gamgort reported acquiring additional deferred stock units linked to the company’s common stock. On 01/09/2026, he received 97.66 deferred stock units in an exempt transaction under the 2005 Director Deferred Fee Plan, based on a weighted average share price of $345.6. Each deferred stock unit is economically equivalent to one share and is payable in stock, generally after his service as a director ends.
Following this transaction, Gamgort held 380.04 deferred stock units under the Deferred Fee Plan on an indirect basis and separately held 517 restricted stock units directly, each RSU representing the right to receive one share of common stock.
Sherwin-Williams director Kerrii B. Anderson reported a small equity award. On January 9, 2026, the director acquired 28.94 deferred stock units of Sherwin-Williams common stock in an exempt transaction under the company’s 2005 Director Deferred Fee Plan. These deferred stock units are economically equivalent to common shares and are credited at a weighted average share price of $345.60, becoming payable in stock, generally after the director leaves the board.
Following this transaction, Anderson indirectly holds 1,010.94 deferred stock units under the Deferred Fee Plan. The director also directly holds 5,261 securities, consisting of 1,150 restricted stock units and 4,111 shares of common stock, where each restricted stock unit represents the right to receive one share.
The Sherwin-Williams Company’s SVP - Finance and CFO, Benjamin E. Meisenzahl, reported his initial beneficial ownership of company securities as of 01/01/2026. He holds 5,673.4 shares of common stock directly and an additional 257.12 shares indirectly through The Sherwin-Williams Company 401(k) Plan based on the trustee’s 12/31/2025 statement.
He also reports multiple employee stock options, each giving the right to buy Sherwin-Williams common stock at fixed exercise prices, with expiration dates ranging from 10/17/2027 to 10/19/2035. These grants were issued under the company’s equity incentive plans and typically vest in three annual installments starting one year after the grant date, with more recent awards subject to vesting conditions.
Sherwin-Williams (SHW) senior vice president, finance & CFO reported several equity transactions on 12/01/2025. The filing shows exercises of employee stock options to buy 338 shares at $295.83 and 464 shares at $215.08, coded as option exercises (M). Related dispositions of 290 shares at $344.17 and 289 shares at $344.32 were reported with code F, indicating shares withheld or sold to cover taxes.
After these transactions, the executive directly owns 13,273–13,562 shares of common stock, which include 8,350 restricted stock units and varying common share amounts as explained in the footnotes. The filing also reports 1,175.56 shares in a 401(k) plan, 38,500 shares held by a trust, and 20,974 shares held by the spouse, all reported as indirect ownership. Remaining employee stock options total 15,662 and 14,336 options from grants made in October 2021 and October 2022, which vested in three annual installments.
The Sherwin-Williams Company entered into an Amended and Restated Credit Agreement with Citicorp USA, Inc. and a group of lenders to extend the maturity of $75,000,000 of existing credit commitments. The maturity of these borrowings and related letter of credit commitments is being pushed back from December 20, 2025 to December 20, 2030, helping maintain access to this portion of its revolving credit capacity for a longer period. The amended agreement keeps representations, warranties, covenants and events of default substantially the same as under the prior 2016 credit agreement.
The Sherwin-Williams Company amended its long-standing Credit Agreement to extend the maturity of $125,000,000 of available commitments for borrowings and letters of credit from December 20, 2025 to December 20, 2030.
The amendment (No. 21) was executed with Citicorp USA, Inc. as administrative agent and issuing bank, together with the lenders party thereto. The company notes that certain lenders and their affiliates have provided, and may continue to provide, banking and financial services for customary fees.